IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v39y2021i6d10.1007_s40273-021-01042-5.html
   My bibliography  Save this article

Cluster Analysis of Care Pathways in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior in the USA

Author

Listed:
  • Maryia Zhdanava

    (Analysis Group, Inc.)

  • Jennifer Voelker

    (Janssen Scientific Affairs, LLC)

  • Dominic Pilon

    (Analysis Group, Inc.)

  • Tom Cornwall

    (Analysis Group, Inc.)

  • Laura Morrison

    (Analysis Group, Inc.)

  • Maude Vermette-Laforme

    (Analysis Group, Inc.)

  • Patrick Lefebvre

    (Analysis Group, Inc.)

  • Abigail I. Nash

    (Janssen Scientific Affairs, LLC)

  • Kruti Joshi

    (Janssen Scientific Affairs, LLC)

  • Cheryl Neslusan

    (Janssen Scientific Affairs, LLC)

Abstract

Background and Objective Suicidal ideation or behavior are core symptoms of major depressive disorder (MDD). This study aimed to understand heterogeneity among patients with MDD and acute suicidal ideation or behavior. Methods Adults with a diagnosis of MDD on the same day or 6 months before a claim for suicidal ideation or behavior (index date) were identified in the MarketScan® Databases (10/01/2014–04/30/2019). A mathematical algorithm was used to cluster patients on characteristics of care measured pre-index. Patient care pathways were described by cluster during the 12-month pre-index period and up to 12 months post-index. Results Among 38,876 patients with MDD and acute suicidal ideation or behavior, three clusters were identified. Across clusters, pre-index exposure to mental healthcare was revealed as a key differentiator: Cluster 1 (N = 16,025) was least exposed, Cluster 2 (N = 5640) moderately exposed, and Cluster 3 (N = 17,211) most exposed. Patients whose MDD diagnosis was first observed during their index event comprised 86.0% and 72.8% of Clusters 1 and 2, respectively; in Cluster 3, all patients had an MDD diagnosis pre-index. Within 30 days post-index, in Clusters 1, 2, and 3, respectively, 79.3%, 85.2%, and 88.2% used mental health services, including outpatient visits for MDD. Within 12 months post-index, 61.5%, 91.5%, and 84.6% had one or more antidepressant claim, respectively. Per-patient index event costs averaged $5614, $6645, and $5853, respectively. Conclusions Patients with MDD and acute suicidal ideation or behavior least exposed to the healthcare system pre-index similarly received the least care post-index. An opportunity exists to optimize treatment and follow-up with mental health services.

Suggested Citation

  • Maryia Zhdanava & Jennifer Voelker & Dominic Pilon & Tom Cornwall & Laura Morrison & Maude Vermette-Laforme & Patrick Lefebvre & Abigail I. Nash & Kruti Joshi & Cheryl Neslusan, 2021. "Cluster Analysis of Care Pathways in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior in the USA," PharmacoEconomics, Springer, vol. 39(6), pages 707-720, June.
  • Handle: RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01042-5
    DOI: 10.1007/s40273-021-01042-5
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40273-021-01042-5
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40273-021-01042-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. David Proudman & Paul Greenberg & Dave Nellesen, 2021. "The Growing Burden of Major Depressive Disorders (MDD): Implications for Researchers and Policy Makers," PharmacoEconomics, Springer, vol. 39(6), pages 619-625, June.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01042-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.